Immuneering Corporation (IMRX) EBITDA
- 2026-06-30: Basis Reported; EBITDA -$18.92M; Operating income (m); Depreciation and amortization (m).
- 2026-03-31: Basis Reported; EBITDA -$15.25M; Operating income (m); Depreciation and amortization (m).
- 2025-12-31: Basis Reported; EBITDA -$13.68M; Operating income (m); Depreciation and amortization (m).
- 2025-09-30: Basis Reported; EBITDA -$15.3M; Operating income (m); Depreciation and amortization (m).
Complete source-backed ebitda history.
- Available history
- 2022-06-30 to 2026-06-30
- Data captured
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2026-06-30 | Reported | -$18.92M | (m) | (m) | (m) | (m) | $27.37K* | -$16.50M* | (m) | $14.00M | (m) | (m) |
|---|
| 2026-03-31 | Reported | -$15.25M | (m) | (m) | (m) | (m) | $79.93K | -$18.43M | (m) | $10.65M | (m) | (m) |
|---|
| 2025-12-31 | Reported | -$13.68M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2025-09-30 | Reported | -$15.3M | (m) | (m) | (m) | (m) | $7.25K* | -$11.98M* | (m) | $10.87M | (m) | (m) |
|---|
| 2025-06-30 | Reported | -$14.67M | (m) | (m) | (m) | (m) | $2.12K* | -$9.45M* | (m) | $10.45M | (m) | (m) |
|---|
| 2025-03-31 | Reported | -$15.4M | (m) | (m) | (m) | (m) | $8.95K | -$14.08M | (m) | $11.47M | (m) | (m) |
|---|
| 2024-12-31 | Reported | -$18.47M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2024-09-30 | Reported | -$15.18M | (m) | (m) | (m) | (m) | $5.27K* | -$13.47M* | (m) | $11.25M | (m) | (m) |
|---|
| 2024-06-30 | Reported | -$14.82M | (m) | (m) | (m) | (m) | $32.77K* | -$11.53M* | (m) | $10.65M | (m) | (m) |
|---|
| 2024-03-31 | Reported | -$15.24M | (m) | (m) | (m) | (m) | $37.48K | -$15.49M | (m) | $11.20M | (m) | (m) |
|---|
| 2023-12-31 | Reported | -$16.21M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2023-09-30 | Reported | -$13.85M | (m) | (m) | (m) | (m) | $57.15K* | -$12.03M* | (m) | $10.05M | (m) | (m) |
|---|
| 2023-06-30 | Reported | -$13.43M | (m) | (m) | (m) | (m) | $86.69K* | -$10.75M* | (m) | $9.45M | (m) | (m) |
|---|
| 2023-03-31 | Reported | -$14.6M | (m) | (m) | (m) | (m) | $27.99K | -$14.42M | (m) | $10.21M | (m) | (m) |
|---|
| 2022-09-30 | Reported | -$13.12M | (m) | (m) | (m) | (m) | $393.13K* | -$10.62M* | (m) | $9.36M | (m) | (m) |
|---|
| 2022-06-30 | Reported | -$11.59M | (m) | (m) | (m) | (m) | $165.00K* | -$9.45M* | (m) | $7.98M | (m) | (m) |
|---|
| 2022-03-31 | Reported | (m) | -$12.93M | (m) | (m) | (m) | $115.05K | -$12.28M | (m) | $9.06M | (m) | (m) |
|---|
| 2021-09-30 | Reported | (m) | -$8.54M | (m) | (m) | (m) | $11.35K* | -$9.03M* | (m) | $6.21M | (m) | (m) |
|---|
| 2021-06-30 | Reported | (m) | -$7.99M | (m) | (m) | (m) | $19.82K* | -$6.44M* | (m) | $6.99M | (m) | (m) |
|---|
| 2021-03-31 | Reported | (m) | -$6.24M | (m) | (m) | (m) | $16.56K | -$6.14M | (m) | $5.39M | (m) | (m) |
|---|
| 2020-09-30 | Reported | (m) | -$4.40M | (m) | (m) | (m) | $5.60K* | -$3.49M* | (m) | $4.07M | (m) | (m) |
|---|
| 2020-06-30 | Reported | (m) | -$3.61M | (m) | (m) | (m) | (m) | (m) | (m) | $3.22M | (m) | (m) |
|---|
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2025-12-31 | Reported | -$59.05M | (m) | (m) | (m) | (m) | $142.23K | -$45.34M | (m) | $42.05M | (m) | $0.00 |
|---|
| 2024-12-31 | Reported | -$63.72M | (m) | (m) | (m) | (m) | $84.88K | -$55.00M | (m) | $47.96M | (m) | (m) |
|---|
| 2023-12-31 | Reported | -$58.09M | (m) | (m) | (m) | (m) | $342.75K | -$48.97M | (m) | $41.62M | (m) | (m) |
|---|
| 2022-12-31 | Reported | (m) | -$51.74M | (m) | (m) | (m) | $742.48K | -$44.10M | (m) | $36.27M | (m) | (m) |
|---|
| 2021-12-31 | Reported | (m) | -$33.89M | (m) | (m) | (m) | $60.79K | -$30.85M | (m) | $26.54M | (m) | -$307.49K |
|---|
| 2020-12-31 | Reported | (m) | -$17.08M | (m) | (m) | (m) | $53.41K | -$14.62M | (m) | $15.00M | (m) | (m) |
|---|